澳大利亚的一项重大试验发现,外科手术后的低剂量辐射可能会减少Dupuytren病的复发,但结果尚未确定。 A major Australian trial finds low-dose radiation after surgery may reduce recurrence in Dupuytren’s disease, with results pending.

在澳大利亚纽卡斯尔(Newcastle)的大规模临床试验正在测试低剂量辐射疗法与外科手术相结合,以防止Dupuytren的病情发展,这一遗传病影响到高达20%的50岁以上成年人,特别是北欧后裔。 A large-scale clinical trial in Newcastle, Australia, is testing low-dose radiation therapy combined with surgery to prevent Dupuytren’s disease progression, a hereditary condition affecting up to 20% of adults over 50, particularly those of Northern European descent. 由Jarad Martin教授牵头的DEPART试验显示,早期结果显示,治疗效果良好,副作用微乎其微,为降低高复发率提供了希望。 Led by Professor Jarad Martin, the DEPART trial shows early results indicating the treatment is well-tolerated with minimal side effects, offering hope for reducing high recurrence rates. 这项研究被认为是世界上同类研究中最大的一项,预计将在两年内继续取得最终结果。 The study, considered the world’s largest of its kind, continues with final results expected in two years.